Akimoto K, Nakaya M, Yamanaka T, Tanaka J, Matsuda S, Weng Q P, Avruch J, Ohno S
Department of Molecular Biology, Yokohama City University School of Medicine, 3-9 Fuku-ura, Kanazawa-ku, Yokohama 236, Japan.
Biochem J. 1998 Oct 15;335 ( Pt 2)(Pt 2):417-24. doi: 10.1042/bj3350417.
p70 S6 kinase (p70 S6K) has been implicated in the regulation of cell cycle progression. However, the mechanism of its activation is not fully understood. In the present work, evidence is provided that an atypical protein kinase C (PKC) isotype, PKClambda, is indispensable, but not sufficient, for the activation of p70 S6K. Both the regulatory and kinase domains of PKClambda associate directly with p70 S6K. Overexpression of the kinase domain without kinase activity or the regulatory domain of PKClambda results in the suppression of the serum-induced activation of p70 S6K. In addition, two types of dominant-negative mutants of PKClambda, as well as a kinase-deficient mutant of p70 S6K, suppress serum-induced DNA synthesis and E2F activation. The overexpresion of the active form of PKClambda, however, fails to activate p70 S6K. These results suggest that PKClambda is a mediator in the regulation of p70 S6K activity and plays an important role in cell cycle progression.
p70核糖体蛋白S6激酶(p70 S6K)与细胞周期进程的调控有关。然而,其激活机制尚未完全明确。在本研究中,有证据表明,一种非典型蛋白激酶C(PKC)亚型,即PKClambda,对于p70 S6K的激活是必不可少的,但并非充分条件。PKClambda的调节结构域和激酶结构域均直接与p70 S6K相关联。无激酶活性的激酶结构域或PKClambda的调节结构域的过表达会导致血清诱导的p70 S6K激活受到抑制。此外,两种PKClambda显性负性突变体以及p70 S6K的激酶缺陷型突变体均能抑制血清诱导的DNA合成和E2F激活。然而,PKClambda活性形式的过表达未能激活p70 S6K。这些结果表明,PKClambda是p70 S6K活性调控中的一个介质,在细胞周期进程中发挥重要作用。